首页> 外文期刊>Journal of pharmaceutical sciences. >Crystal structure determination of mebendazole form A using high-resolution synchrotron x-ray powder diffraction data.
【24h】

Crystal structure determination of mebendazole form A using high-resolution synchrotron x-ray powder diffraction data.

机译:使用高分辨率同步加速器X射线粉末衍射数据测定甲苯达唑A型的晶体结构。

获取原文
获取原文并翻译 | 示例
       

摘要

The crystal structure determination of mebendazole form A, an anthelmintic drug, was performed for the first time by applying the DASH software program to synchrotron X-ray powder diffraction data, and supported by a satisfying Rietveld fit. This polymorph of mebendazole crystallizes in a triclinic (P1) space group, with unit-cell parameters a = 5.5044(2) A, b = 11.2872(2) A, c = 12.5276(5) A, alpha = 66.694(2) degrees, beta = 82.959(2) degrees, gamma = 78.443(2) degrees, V = 699.52(5) A(3), Z = 2, M = 295.293 g mol(-1), rho(calc) = 1.4021 g cm(-3), and rho(meas) = 1.3935(66) g cm(-3), which were obtained by means of the unit-cell formula weight and a picnometric measurement, respectively. The goodness-of-fit and R-factors were, respectively: chi(2) = 1.746, R(F)(2) = 1.69%, R(wp) = 5.72%, and R(p) = 4.37%. A weak nonclassical hydrogen bond involving the atoms N(3)-H(23)...O(11) may be responsible for the greater stability of the polymorphic form A of mebendazole due to the strongest electronegativity of nitrogen.
机译:通过将DASH软件程序应用于同步加速器X射线粉末衍射数据,首次进行了抗虫药甲苯达唑A的晶体结构测定,并得到了令人满意的Rietveld拟合支持。甲苯达唑的多晶型物在三斜(P1)空间群中结晶,晶胞参数a = 5.5044(2)A,b = 11.2872(2)A,c = 12.5276(5)A,alpha = 66.694(2)度,beta = 82.959(2)度,gamma = 78.443(2)度,V = 699.52(5)A(3),Z = 2,M = 295.293 g mol(-1),rho(calc)= 1.4021 g cm (-3)和rho(meas)= 1.3935(66)g cm(-3),它​​们分别是通过晶胞配方重量和皮克法测量获得的。拟合优度和R因子分别为:chi(2)= 1.746,R(F)(2)= 1.69%,R(wp)= 5.72%和R(p)= 4.37%。涉及原子N(3)-H(23)... O(11)的弱非经典氢键可能是由于最强​​的氮电负性导致的甲苯达唑多晶型A的更大稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号